|
Insilicare: AI-Powered Digital Twins for Clinical Decision Support Insilicare is a spinoff company specializing in the development of clinical decision support systems as medical devices. Our technology, founded on unique, patented digital twin and predictive AI technology, enables the delivery of safe, effective treatment through a personalized medicine approach. Our flagship product, Glucomeo™, is an automated, personalized, risk-based clinical decision support tool designed to provide real-time insights, impact assessments, and risk evaluations associated with insulin treatment. Glucomeo™ empowers healthcare professionals with actionable information to optimize glucose management and improve patient outcomes. Insilicare is committed to advancing healthcare through cutting-edge technology, driving positive change in patient care, and optimizing healthcare resources. Our vision is to be at the forefront of AI-powered clinical decision support systems, shaping the future of healthcare delivery and improving the quality of care. |
